Scientists say IRX4204 given to mice with evident symptoms showed potential "as a remyelinating and neurorestorative ...
Long-term Tecfidera use was found to significantly reduce relapse rates and slow disability progression for MS patients in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback